1887

Journal of Medical Microbiology logo

Volume 62, Issue 4

IgG2 response and low IgG titre specific to CagA as serological markers for gastric cancer Free

Abstract

Infection with cytotoxin-associated gene A (CagA)-positive strains is associated with the development of gastric cancer (GC). However, some reports have failed to demonstrate an increased frequency of CagA antibodies in GC patients. This study evaluated the response of IgG antibody and subclasses IgG1 and IgG2 against both CagA and membrane antigens in patients with pre-cancerous lesions and cases with GC. A total of 137 patients with a positive serum IgG response to were selected: 46 with intestinal metaplasia, 41 with gastric adenocarcinoma and 50 with non-atrophic gastritis (NAG) considered as controls. The response of total IgG, IgG1 and IgG2 was investigated by immunoblot and ELISA using an in-house recombinant CagA and membrane antigens from a local strain, and possible associations were estimated using a logistic regression model. Compared with NAG patients, GC patients showed a higher frequency of IgG2 CagA antibodies (55.2 vs 15.4 %,  = 0.001), but a lower frequency (80.5 vs 96.0 %,  = 0.021) and diminished levels of IgG2 antibodies [12.5 vs 21.9 ELISA units (EU),  = 0.007]. GC patients also presented lower levels of CagA (32.6 vs 42.4 EU,  = 0.004) and total IgG (33.7 vs 38.7 EU,  = 0.029). GC was associated with a positive IgG2 CagA response [odds ratio (OR) = 3.74, 95 % confidence interval (CI) 1.81–5.37;  = 0.002] and with a low titre of total IgG CagA antibodies (OR = 2.18, 95 % CI 1.35–2.69;  = 0.006). These results suggest that the IgG2 response to CagA could be used as a novel serological marker to identify patients with associated GC.

  • Received:
  • Accepted:
  • Published Online:
© 2013 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.050567-0
2013-04-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/4/591.html?itemId=/content/journal/jmm/10.1099/jmm.0.050567-0&mimeType=html&fmt=ahah

References

  1. Anderhuber W., Steinschifter W., Schauenstein E., Gotschuli A., Habermann W., Fischer M., Felsner P., Schauenstein K. 1999; The IgG1/G2 subclass shift – a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neck. Br J Cancer 79:1777–1781 [View Article][PubMed]
     [Google Scholar]
  2. Ayala G., Torres-Mena J., López-Carrillo L. 2008; Association between Helicobacter pylori VacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of VacA. J Med Microbiol 57:9–14 [View Article][PubMed]
     [Google Scholar]
  3. Backert S., Tegtmeyer N., Selbach M. 2010; The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 15:163–176 [View Article][PubMed]
     [Google Scholar]
  4. Bergman M. P., Engering A., Smits H. H., van Vliet S. J., van Bodegraven A. A., Wirth H. P., Kapsenberg M. L., Vandenbroucke-Grauls C. M., van Kooyk Y., Appelmelk B. J. 2004; Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 200:979–990 [View Article][PubMed]
     [Google Scholar]
  5. Bergman M., Del Prete G., van Kooyk Y., Appelmelk B. 2006; Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat Rev Microbiol 4:151–159 [View Article][PubMed]
     [Google Scholar]
  6. Brown L. M. 2000; Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283–297 [View Article][PubMed]
     [Google Scholar]
  7. Camorlinga-Ponce M., Flores-Luna L., Lazcano-Ponce E., Herrero R., Bernal-Sahagún F., Abdo-Francis J. M., Aguirre-García J., Muñoz N., Torres J. 2008; Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Cancer Epidemiol Biomarkers Prev 17:2498–2504 [View Article][PubMed]
     [Google Scholar]
  8. Chomvarin C., Ottiwet O., Hahnvajanawong C., Intapan P. M., Wongwajana S. 2009; Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Int J Infect Dis 13:647–654 [View Article][PubMed]
     [Google Scholar]
  9. Correa P. 1996; Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev 5:477–481[PubMed]
     [Google Scholar]
  10. D’Elios M. M., Manghetti M., Almerigogna F., Amedei A., Costa F., Burroni D., Baldari C. T., Romagnani S., Telford J. L., Del Prete G. 1997; Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 27:1751–1755 [View Article][PubMed]
     [Google Scholar]
  11. Du Y., Agnew A., Ye X. P., Robinson P. A., Forman D., Crabtree J. E. 2006; Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio. Microbes Infect 8:52–60 [View Article][PubMed]
     [Google Scholar]
  12. Dzierzanowska-Fangrat K., Raeiszadeh M., Dzierzanowska D., Gladkowska-Dura M., Celinska-Cedro D., Crabtree J. E. 2003; IgG subclass response to Helicobacter pylori and CagA antigens in children. Clin Exp Immunol 134:442–446 [View Article][PubMed]
     [Google Scholar]
  13. Eslick G. D., Lim L. L., Byles J. E., Xia H. H., Talley N. J. 1999; Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94:2373–2379 [View Article][PubMed]
     [Google Scholar]
  14. Haddada M. H., Escribano M. J., De Vaux Saint Cyr C., Barra Y. 1984; Variations in the levels of IgG1 and IgG2 subclasses in the sera of normal, immunized and tumor-bearing hamsters. Eur J Cancer Clin Oncol 20:553–560 [View Article][PubMed]
     [Google Scholar]
  15. Huang J. Q., Sridhar S., Chen Y., Hunt R. H. 1998; Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169–1179 [View Article][PubMed]
     [Google Scholar]
  16. Huang J. Q., Zheng G. F., Sumanac K., Irvine E. J., Hunt R. H. 2003; Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125:1636–1644 [View Article][PubMed]
     [Google Scholar]
  17. Hussain R., Kifayet A., Chiang T. J. 1995; Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy. Infect Immun 63:410–415[PubMed]
     [Google Scholar]
  18. IARC Working Group 1994; Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:1–241[PubMed]
     [Google Scholar]
  19. Lagacé J., Péloquin L., Kermani P., Montie T. C. 1995; IgG subclass responses to Pseudomonas aeruginosa a- and b-type flagellins in patients with cystic fibrosis: a prospective study. J Med Microbiol 43:270–276 [View Article][PubMed]
     [Google Scholar]
  20. Lin W.-C., Tsai H.-F., Kuo S.-H., Wu M.-S., Lin C.-W., Hsu P.-I., Cheng A.-L., Hsu P.-N. 2010; Translocation of Helicobacter pylori CagA into human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res 70:5740–5748 [View Article][PubMed]
     [Google Scholar]
  21. Lottenbach K. R., Mink C. M., Barenkamp S. J., Anderson E. L., Homan S. M., Powers D. C. 1999; Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. Infect Immun 67:4935–4938[PubMed]
     [Google Scholar]
  22. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275[PubMed]
     [Google Scholar]
  23. Mattsson A., Tinnert A., Hamlet A., Lönroth H., Bölin I., Svennerholm A. M. 1998; Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin Diagn Lab Immunol 5:288–293[PubMed]
     [Google Scholar]
  24. Mitchell H. M., Mascord K., Hazell S. L., Daskalopoulos G. 2001; Association between the IgG subclass response, inflammation and disease status in Helicobacter pylori infection. Scand J Gastroenterol 36:149–155 [View Article][PubMed]
     [Google Scholar]
  25. Mitchell H. M., Ally R., Wadee A., Wiseman M., Segal I. 2002; Major differences in the IgG subclass response to Helicobacter pylori in the first and third worlds. Scand J Gastroenterol 37:517–522 [View Article][PubMed]
     [Google Scholar]
  26. Mitchell P., Germain C., Fiori P. L., Khamri W., Foster G. R., Ghosh S., Lechler R. I., Bamford K. B., Lombardi G. 2007; Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun 75:810–819 [View Article][PubMed]
     [Google Scholar]
  27. Monack D. M., Mueller A., Falkow S. 2004; Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2:747–765 [View Article][PubMed]
     [Google Scholar]
  28. Nomura A. M., Lee J., Stemmermann G. N., Nomura R. Y., Perez-Perez G. I., Blaser M. J. 2002; Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 186:1138–1144 [View Article][PubMed]
     [Google Scholar]
  29. Parkin D. M., Bray F., Ferlay J., Pisani P. 2005; Global cancer statistics, 2002. CA Cancer J Clin 55:74–108 [View Article][PubMed]
     [Google Scholar]
  30. Peek R. M. Jr, Miller G. G., Tham K. T., Perez-Perez G. I., Zhao X., Atherton J. C., Blaser M. J. 1995; Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 73:760–770[PubMed]
     [Google Scholar]
  31. Ren Z., Pang G., Clancy R., Li L. C., Lee C. S., Batey R., Borody T., Dunkley M. 2001; Shift of the gastric T-cell response in gastric carcinoma. J Gastroenterol Hepatol 16:142–148 [View Article][PubMed]
     [Google Scholar]
  32. Ren Z., Borody T., Pang G., Li L. C., Dunkley M., Clancy R. 2005; Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma. J Gastroenterol Hepatol 20:1338–1343 [View Article][PubMed]
     [Google Scholar]
  33. Schauenstein E., Rabl H., Steinschifter W., Hirschmann C., Estelberger W., Schauenstein K. 1997; Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissue. Cancer 79:1482–1486 [View Article][PubMed]
     [Google Scholar]
  34. Schumann C., Triantafilou K., Rasche F. M., Möricke A., Vogt K., Triantafilou M., Hahn P., Schneider E. M., Lepper P. M. 2006; Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol 296:223–228 [View Article][PubMed]
     [Google Scholar]
  35. Suzuki G., Cullings H., Fujiwara S., Hattori N., Matsuura S., Hakoda M., Akahoshi M., Kodama K., Tahara E. 2007; Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev 16:1224–1228 [View Article][PubMed]
     [Google Scholar]
  36. Wan Y. Y., Flavell R. A. 2009; How diverse – CD4 effector T cells and their functions. J Mol Cell Biol 1:20–36 [View Article][PubMed]
     [Google Scholar]
  37. Weblacher M., Leitsberger A., Tillian H., Maninger K., Estelberger W., Schauenstein K., Schauenstein E. 1993; A decrease in reactive disulfide bonds of serum IgG signals a characteristic change in the IgG subclass patterns of rats bearing experimental tumors. Int Arch Allergy Immunol 102:340–346 [View Article][PubMed]
     [Google Scholar]
  38. Yamaji Y., Mitsushima T., Ikuma H., Okamoto M., Yoshida H., Kawabe T., Shiratori Y., Saito K., Yokouchi K., Omata M. 2002; Weak response of Helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10,234 endoscoped Japanese. Scand J Gastroenterol 37:148–153 [View Article][PubMed]
     [Google Scholar]
  39. Yamaoka Y., Kita M., Kodama T., Sawai N., Kashima K., Imanishi J. 1997; Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442–451 [View Article][PubMed]
     [Google Scholar]
  40. Yamaoka Y., Kodama T., Kashima K., Graham D. Y. 1999; Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol 52:215–218 [View Article][PubMed]
     [Google Scholar]
  41. Yokota S., Amano K., Hayashi S., Fujii N. 1997; Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumors of patients with gastric cancer. Infect Immun 65:3509–3512[PubMed]
     [Google Scholar]
  42. Yokota Si., Amano Ki., Hayashi S., Kubota T., Fujii N., Yokochi T. 1998; Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide. Infect Immun 66:3006–3011[PubMed]
     [Google Scholar]
  43. Zhang J., Yu K. F. 1998; What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690–1691 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.050567-0
Loading
IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer
J. Med. Microbiol. 62, 591 (2013); https://doi.org/10.1099/jmm.0.050567-0
/content/journal/jmm/10.1099/jmm.0.050567-0
/content/journal/jmm/10.1099/jmm.0.050567-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error